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Summary. L-Cysteic acid and its esters were prepared in good yields
from the oxidation of L-cystine by chlorine in water and in alcohols. When
the reaction was carried out in alcohols the corresponding esters were
produced.
Keywords: L-Cysteic acid – L-Cysteic acid ester – L-Cystine – Oxida-
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Introduction
Cysteic acid, a nontoxic and nonallergenic physiologic
compound, was found in human and animal blood, espe-
cially in the platelets and leukocytes. It was discovered
that ichthyotic conditions may be treated with cysteic
acid, homocysteic acid or cysteine sulfinic acid. Also
the unpleasant odor of the body and skin disorders such
as dandruff, acne, psoriasis, palmar and plantar hyperker-
atosis may be treated with cysteic acid, homocysteic acid
or their metal complex (Yu and Vanscott, 1977). Polycys-
teic acid synthesized from cysteic acid was found to inhib-
it the cytopathic effect of HIV-1 in CEM cell cultures at
concentrations that were not cytotoxic to uninfected CEM
cells (Young-im and Cushman, 1994). Applied largely in
the pharmaceutical and cosmetic industry, zinc cysteate
was prepared from a zinc salt, zinc oxide or hydroxide,
with cysteic acid or its salts (Jean and Oliver, 1990). Hair
dye agents containing cysteic acid can keep hair elastic
and humid (Mustefa and Herbert, 1997). A novel non-
phosphorus chelant, ethylene aspartate cysteate (EAC)
sequestrants prepared from DL-cysteic acid or L-cysteic
acid, can be used as a replacement for all or part of the
chelants currently used in many existing laundry products
(Wu et al., 1997).
Usually, L-cysteic acid was prepared from the oxida-
tion of L-cystine in HCl solution with bromine (Clarke,
1966) or hydrogen peroxide (Lipton et al., 1977) as oxi-
dizing reagent. The oxidation of L-cystine with dimethyl
sulfoxide under the catalysis of I2-HCl can give L-cysteic
acid (Lowe, 1977). The yields of the above strategies were
acceptable but the work-ups were tedious. L-Cysteic acid
esters were synthesized from esterification of L-cysteic
acid with corresponding alcohols (Rosowsky et al.,
1984; Tanaka and Izumiya, 1959). Herein we report an
efficient preparation method of L-cysteic acid and its
esters.
Results and discussion
According to Scheme 1, L-cysteic acid and its esters
(2–10) were prepared with good yields from the direct
oxidation of L-cystine (1) by chlorine in water or alcohols
at room temperature. The results are summarized in Table 1.
It should be noted that L-cystine was dissolved slowly
in the corresponding solvents when chlorine was passed
into the reaction vessel with stirring. The esters were pre-
cipitated from the reaction mixture, which lead to the
reaction mixture solidified slowly. The solids were col-
lected and then crystalized in methanol to give the esters.
In the case of L-cysteic acid, concentration of the reaction
mixture lead to the crystallization of L-cysteic acid. All




Melting points were measured on an XRC-1 melting point apparatus
and are uncorrected. 1H-NMR and 13C-NMR spectra were recorded on
a Bruker Advance 600 spectrometer with TMS as an internal standard.
ESIMS were obtained on a Finnigan LCQDECA mass spectrometer. Optical
rotations were measured on a Perkin-Elmer model 341 automatic polar-
imeter. IR spectra were carried out on a Perkin-Elmer Spectrum One
spectrometer in KBr discs.
General procedure for preparation of L-cysteic acid and its ester
1.0 g of L-cystine was suspended in 15 ml water or alcohols. Chlorine was
passed into the mixture under stirring at room temperature. Excess chlo-
rine was piped out and absorbed by 5% NaOH (aq.) solution. The reaction
mixture solidified slowly. The solid was collected and crystallized from
methanol to give the corresponding products.
L-Cysteic acid (2): Colorless plates crystal; m.p. 256–257C [lit.
257–258C (Clarke, 1966)]; ½20D ¼þ10.2 (c¼ 3.0, 1N HCl) [lit.
[]54246¼þ9.36 (c¼ 6.0, H2O) (Clarke, 1966)]; IR: max (cm1)¼
3394 (NH), 3164, 3000 2500 (–COOH), 1766 (C¼O), 1618, 1576,
1504, 1418, 1364, 1240, 1220, 1169, 1032 and 711 (S¼O), 1131, 1082,
1062, 966, 876, 847, 795, 643, 578, 538 and 514; 1H-NMR (600 MHz,
D2O): ¼ 4.36 (1H, dd, J¼ 8.4, 3.3 Hz, 2-H), 3.46 (1H, dd, J¼ 15.1,
3.3 Hz, 3-Ha), 3.34 (1H, dd, J¼ 15.1, 8.4 Hz, 3-Hb); ESIMS (negative
mode) m=z (rel. int.): 168 ([MH], 100).
Methyl L-cysteate (3): White solid; m.p. 220–224C; ½20D ¼þ8.5
(c¼ 3.0, 1N HCl); IR: max (cm1)¼ 3478 (NH), 3177, 3023, 2984,
2920, 1749 (C¼O), 1595, 1496, 1442, 1424, 1373, 1334, 1290, 1273,
1226, 1179, 1032 and 741 (S¼O), 1140, 1102, 978, 931, 889, 846, 803,
623, 600 and 533; 1H-NMR (600 MHz, D2O): ¼ 4.58 (1H, dd, J¼ 7.1,
3.8 Hz, 2-H), 3.85 (3H, s, –OCH3), 3.55 (1H, dd, J¼ 15.1, 3.8 Hz, 3-Ha),
3.49 (1H, dd, J¼ 15.1, 7.1 Hz, 3-Hb); 13C-NMR (150 MHz, D2O):
¼ 168.8, 54.3, 50.0, 49.2; ESIMS (negative mode) m=z (rel. int.): 182
([MH], 100).
Ethyl L-cysteate (4): White solid; m.p. 244–246C [lit. 238–240C
(Tanaka et al., 1959)]; ½20D ¼8.9 (c¼ 3.0, 1N HCl) [lit. ½20D ¼þ4.1
(c¼ 2.0, H2O) (Tanaka et al., 1959)]; IR: max (cm1)¼ 3465 (NH), 2985,
1748 (C¼O), 1603, 1507, 1419, 1382, 1339, 1190, 1042 and 738 (S¼O),
1092, 968, 859, 798, 592 and 524; 1H-NMR (600 MHz, D2O): ¼ 4.53
(1H, dd, J¼ 7.2, 3.8 Hz, 2-H), 4.30 (2H, q, J¼ 7.0 Hz, –OCH2CH3), 3.54
(1H, dd, J¼ 15.1, 3.8 Hz, 3-Ha), 3.48 (1H, dd, J¼ 15.1, 7.2 Hz, 3-Hb),
1.29 (3H, t, J¼ 7.0 Hz, –OCH2CH3); 13C-NMR (150 MHz, D2O):
¼ 168.2, 64.3, 50.0, 49.2, 13.3; ESIMS (negative mode) m=z (rel. int.):
196 ([MH], 100).
n-Propyl L-cysteate (5): White solid; m.p. 248–250C; ½20D ¼1.6
(c¼ 3.0, 1N HCl); IR: max (cm1)¼ 3470 (NH), 3086, 2970, 2940,
1744 (C¼O), 1618, 1504, 1466, 1395, 1376, 1291, 1272, 1250, 1220,
1185, 1047 and 733 (S¼O), 1107, 1070, 927, 873, 855, 812, 588, 547 and
524; 1H-NMR (600 MHz, D2O): ¼ 4.49 (1H, dd, J¼ 7.2, 3.8 Hz, 2-H),
4.14 (2H, m, –OCH2CH2CH3), 3.48 (1H, dd, J¼ 15.1, 3.8 Hz, 3-Ha), 3.43
(1H, dd, J¼ 15.1, 7.2 Hz, 3-Hb), 1.62 (2H, m, –OCH2CH2CH3), 0.85 (3H,
t, J¼ 7.4 Hz, –OCH2CH2CH3); 13C-NMR (150 MHz, D2O): ¼ 168.4,
69.7, 50.0, 49.2, 21.4, 9.7; ESIMS (negative mode) m=z (rel. int.): 210
([MH], 100).
n-Butyl L-cysteate (6): White solid; m.p. 197–198C; ½20D ¼3.0
(c¼ 3.0, 1N HCl); IR: max (cm1)¼ 3436 (NH), 3185, 2959, 2681,
1750 (C¼O), 1592, 1534, 1468, 1420, 1402, 1378, 1276, 1251, 1193,
1039 and 743 (S¼O), 1078, 931, 823, 589, 540 and 523; 1H-NMR
(600 MHz, D2O): ¼ 4.54 (1H, dd, J¼ 7.3, 3.8 Hz, 2-H), 4.27 (2H, m,
–OCH2CH2CH2CH3), 3.54 (1H, dd, J¼ 15.1, 3.8 Hz, 3-Ha), 3.48 (1H, dd,
J¼ 15.1, 7.3 Hz, 3-Hb), 1.66 (2H, m, –OCH2CH2CH2CH3), 1.37 (2H, m,
–OCH2CH2CH2CH3), 0.89 (3H, t, J¼ 7.4 Hz, –OCH2CH2CH2CH3);
13C-NMR (150 MHz, D2O): ¼ 168.3, 68.0, 49.9, 49.2, 29.8, 18.6, 13.1;
ESIMS (negative mode) m=z (rel. int.): 224 ([MH], 100). ESIMS
(positive mode) m=z (rel. int.): 226 ([MþH]þ, 100).
n-Hexyl L-cysteate (7): White needles; m.p. 194–196C; ½20D ¼þ9.3
(c¼ 0.3, MeOH); IR: max (cm1)¼ 3470 (NH), 2595, 2860, 1745 (C¼O),
1602, 1535, 1469, 1421, 1397, 1376, 1341, 1223, 1150, 1039 and 737
(S¼O), 1090, 1070, 999, 908, 886, 797, 643, 606, 534 and 521; 1H-NMR
(600 MHz, D2O): ¼ 4.48 (1H, dd, J ¼ 7.3 , 3.8 Hz, 2-H), 4.20 (2H, m,
–OCH2CH2CH2(CH2)2CH3), 3.48 (1H, dd, J¼ 15.1, 3.8 Hz, 3-Ha), 3.42
(1H, dd, J¼ 15.1, 7.3 Hz, 3-Hb), 1.62 (2H, m, –OCH2CH2CH2(CH2)2CH3),





CH3) 0.79 (3H, t, J¼ 7.1 Hz, –OCH2CH2CH2(CH2)2CH3);
Table 1. Oxidation of L-cystine by chlorine
Compounds R Solvent Time (min) Yield (%)
2 H H2O 15 70.3
a
3 CH3 CH3OH 8 93.1
b
4 CH3CH2 CH3CH2OH 7 84.7
c
5 CH3CH2CH2 CH3CH2CH2OH 35 88.6
6 CH3(CH2)2CH2 CH3(CH2)2CH2OH 20 85.5
7 CH3(CH2)4CH2 CH3(CH2)4CH2OH 25 80.2
8 CH3(CH2)6CH2 CH3(CH2)6CH2OH 35 74.6
9 (CH3)2CH (CH3)2CHOH 20 82.7
10 (CH3)2CHCH2 (CH3)2CHCH2OH 35 75.8
a 81–90% (Clarke, 1966), b 100% from L-cysteic acid (Rosowsky et al., 1984), c 93% from L-cysteic acid
(Tanaka and Izumiya, 1959)
Scheme 1
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13C-NMR (150 MHz, D2O): ¼ 168.4, 68.3, 50.0, 49.2, 30.8, 27.7, 24.9,
22.1, 13.5; ESIMS (negative mode) m=z (rel. int.): 252 ([MH], 100).
n-Octyl L-cysteate (8): White needles; m.p. 184–188C; ½20D ¼þ7.0
(c¼ 0.3, MeOH); IR: max (cm1)¼ 3473 (NH), 2926, 2856, 1746 (C¼O),
1601, 1536, 1468, 1420, 1399, 1377, 1340, 1195, 1040 and 736
(S¼O), 1090, 945, 883, 847, 821, 736, 606, 591 and 532; 1H-NMR
(600 MHz, CD3OD): ¼ 4.40 (1H, dd, J¼ 9.2, 3.1 Hz, 2-H), 4.26 (2H,
m, –OCH2CH2CH2(CH2)4CH3), 3.37 (1H, dd, J¼ 14.6, 3.1 Hz, 3-Ha),
3.24 (1H, dd, J¼ 14.6, 9.2 Hz, 3-Hb), 1.72 (2H, m, –OCH2CH2CH2
(CH2)4CH3), 1.39 (2H, m, –OCH2CH2CH2 (CH2)4CH3), 1.32 (8H, m,
–OCH2CH2CH2ðCH2Þ4CH3), 0.90 (3H, t, J¼ 7.0 Hz, –OCH2CH2CH2
(CH2)4CH3);
13C-NMR (150 MHz, CD3OD): ¼ 167.7, 67.0, 50.2, 49.1,
31.7, 29.1, 28.2, 25.6, 22.5, 13.2; ESIMS (negative mode) m=z (rel. int.):
280 ([MH], 100).
iso-Propyl L-cysteate (9): White solid; m.p. 220–224C; ½20D ¼16.5
(c¼ 1.0, 1N HCl); IR: max (cm1)¼ 3461 (NH), 3196, 2977, 2676, 1744
(C¼O), 1590, 1533, 1470, 1422, 1383, 1341, 1276, 1195, 1039 and 742
(S¼O), 1101, 1076, 975, 929, 897, 853, 827, 656, 589, 541 and 524; 1H-
NMR (600 MHz, D2O): ¼ 5.1 (1H, m, –OCH(CH3)2), 4.49 (1H, dd,
J¼ 7.5, 3.8 Hz, 2-H), 3.52 (1H, dd, J¼ 15.1, 3.8 Hz, 3-Ha), 3.47 (1H,





(150 MHz, D2O): ¼ 167.6, 73.2, 50.0, 49.1, 20.9, 20.8; ESIMS (negative
mode) m=z (rel. int.): 210 ([MH], 100).
iso-Butyl L-cysteate (10): Colorless plates crystal; m.p. 268–270C;
½20D ¼2.2 (c¼ 1.5, 1N HCl); IR: max (cm)¼ 3468 (NH), 3116,
2991, 2958, 2878, 2737, 2678, 1748 (C¼O), 1582, 1505, 1471,
1423, 1402, 1388, 1373, 1289, 1196, 1043 and 733 (S¼O), 1075, 994,
962, 944, 921, 871, 856, 833, 808, 673, 590, 546 and 523; 1H-NMR
(600 MHz, D2O): ¼ 4.51 (1H, dd, J¼ 7.1, 4.0 Hz, 2-H), 3.98 (2H,
m, –OCH2CH(CH3)2), 3.48 (1H, dd, J¼ 15.1, 4.0 Hz, 3-Ha), 3.44 (1H,
dd, J¼ 15.1, 7.1 Hz, 3-Hb), 1.92 (1H, m, –OCH2CH(CH3)2), 0.86 (6H, d,
J¼ 6.8 Hz, –OCH2CHðCH3Þ2);
13C-NMR (150 MHz, D2O): ¼ 168.4,
73.9, 50.0, 49.2, 18.3; ESIMS (negative mode) m=z (rel. int.): 224
([MH], 100).
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